It has been suggested that certain histological criteria may serve to indicate a good prognosis in patients with esophageal carcinoma. These include absence of subepithelial extension of the carcinoma cells, stage no higher than m2, and no neoplastic involvement near the resection margin. As endoscopic mucosal resection is becoming an accepted treatment option in this type of tumor, prognostic parameters of this type are of particular interest. By contrast, when metastases are detected in the celiac lymph nodes, it implies that the tumor is unresectable and that palliative treatment is required. Endoscopic ultrasound (EUS)-guided fine-needle aspiration has been found to be the most cost-effective option in this setting. Although autofluorescence endoscopy is being tested as a new technique for endoscopic diagnosis, its value is at present unclear. However, such developments may lead to improved diagnosis in the future, particularly in relation to the initial stages of carcinoma. For the moment, EUS is still the most widely accepted method for early diagnosis and staging. Esophageal squamous-cell carcinoma appears to be commonly associated with head and neck cancer, but the cost-effectiveness of surveillance is a matter of controversy. With regard to Barrett’s esophagus and adenocarcinoma, p53 staining in areas of low-grade dysplasia appears to be helpful for predicting progression to high-grade dysplasia. The prevalence of short-segment Barrett’s esophagus increases with age, but the length of the segment does not increase with time; the length probably depends on individual conditions, not merely on elapsed time. Helicobacter pylori infection appears to be associated with intestinal metaplasia at the esophagogastric junction. However, the most recent data appear to suggest that this scenario (usually termed “carditis”) may be different from intestinal metaplasia in the lower esophagus, related to acid reflux. A follow-up program might be able to detect Barrett’s esophagus adenocarcinoma at earlier stages, but only a minority of Barrett’s esophagus patients are likely to be detected before neoplasia has developed. Gastric cancer appears to develop in individuals with H. pylori infection, but not in uninfected persons. In addition, those with severe gastric atrophy, corpus-predominant gastritis, and intestinal metaplasia may be at greater risk for gastric cancer. This again raises the question of H. pylori eradication in asymptomatic individuals with infection, and surveillance of patients with severe intestinal metaplasia. The most recent data appear to support the notion that healing of MALT lymphoma depends not only on H. pylori eradication and on the stage of the tumor, but also on individual factors (possibly immunology-related).
References
1
Abraham S C, Singh V K, Yardley J H, Wu T T.
Hyperplastic polyps of the esophagus and esophagogastric junction: histologic and clinicopathologic findings.
Am J Surg Pathol.
2001;
25
1180-1187
3
Kuwano H, Masuda N, Kato H, Sugimachi K.
The subepithelial extension of esophageal carcinoma for determining the resection margin during esophagectomy: a serial histopathologic investigation.
Surgery.
2002;
131
S14-21
4
Araki K, Ohno S, Egashira A. et al .
Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis.
Cancer.
2002;
94
570-575
5
Dexter S P, Sue-Ling H, McMahon M J. et al .
Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer.
Gut.
2001;
48
667-670
6
Brucher B L, Stein H J, Werner M, Siewert J R.
Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma.
Cancer.
2001;
92
2228-2233
7
Elpek G O, Gelen T, Aksoy N H. et al .
The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus.
J Clin Pathol.
2001;
54
940-944
8
Nakamura T, Ide H, Eguchi R. et al .
Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma.
J Surg Oncol.
2002;
79
224-229
9
Eloubeidi M A, Wallace M B, Reed C E. et al .
The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience.
Gastrointest Endosc.
2001;
54
714-719
10
Mortensen M B, Pless T, Durup J. et al .
Clinical impact of endoscopic ultrasound-guided fine needle aspiration biopsy in patients with upper gastrointestinal tract malignancies: a prospective study.
Endoscopy.
2001;
33
478-483
12
Wakelin S J, Deans C, Crofts T J. et al .
A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma.
Eur J Radiol.
2002;
41
161-167
14
Bhunchet E, Hatakawa H, Sakai Y, Shibata T.
Fluorescein electronic endoscopy: a novel method for detection of early stage gastric cancer not evident to routine endoscopy.
Gastrointest Endosc.
2002;
55
562-571
15
Haringsma J, Tytgat G N, Yano H. et al .
Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology.
Gastrointest Endosc.
2001;
53
642-650
16
Mayinger B, Horner P, Jordan M. et al .
Light-induced autofluorescence spectroscopy for the endoscopic detection of esophageal cancer.
Gastrointest Endosc.
2001;
54
195-201
17
Zuccaro G, Gladkova N, Vargo J. et al .
Optical coherence tomography of the esophagus and proximal stomach in health and disease.
Am J Gastroenterol.
2001;
96
2633-2639
18
Sun S S, Shih C S, Hsu N Y. et al .
Detection of esophageal carcinoma using single-photon emission computed tomography of thallium-201: a preliminary report.
Anticancer Res.
2001;
21
4109-4112
19
Kumagai Y, Inoue H, Nagai K. et al .
Magnifying endoscopy, stereoscopic microscopy, and the microvascular architecture of superficial esophageal carcinoma.
Endoscopy.
2002;
34
369-375
20
Petit T, Georges C, Jung G M. et al .
Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma.
Ann Oncol.
2001;
12
643-646
23
Scotiniotis I A, Kochman M L, Lewis J D. et al .
Accuracy of EUS in the evaluation of Barrett’s esophagus and high-grade dysplasia or intramucosal carcinoma.
Gastrointest Endosc.
2001;
54
689-696
24
Weston A P, Banerjee S K, Sharma P. et al .
p53 protein overexpression in low grade dysplasia (LGD) in Barrett’s esophagus: immunohistochemical marker predictive of progression.
Am J Gastroenterol.
2001;
96
1355-1362
25
Zaninotto G, Avellini C, Barbazza R. et al .
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey.
The Italian Ulcer Study Group “GISU.” Dig Liver Dis.
2001;
33
316-321
26
Benipal P, Garewal H, Sampliner R E. et al .
Short segment Barrett’s esophagus: relationship of age with extent of intestinal metaplasia.
Am J Gastroenterol.
2001;
96
3084-3088
27
Canto M I, Setrakian S, Willis J E. et al .
Methylene blue staining of dysplastic and nondysplastic Barrett’s esophagus: an in vivo and ex vivo study.
Endoscopy.
2001;
33
391-400
28
El-Serag H B, Mason A C, Petersen N, Key C R.
Epidemiological differences between adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia in the USA.
Gut.
2002;
50
368-372
29
Shen B, Ormsby A H, Shen C. et al .
Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.
Cancer.
2002;
94
820-831
30
Gudlaugsdottir S, van Blankenstein M, Dees J, Wilson J H.
A majority of patients with Barrett’s oesophagus are unlikely to benefit from endoscopic cancer surveillance.
Eur J Gastroenterol Hepatol.
2001;
13
639-645
31
Sonnenberg A, Soni A, Sampliner R E.
Medical decision analysis of endoscopic surveillance of Barrett’s oesophagus to prevent oesophageal adenocarcinoma.
Aliment Pharmacol Ther.
2002;
16
41-50
32
Fitzgerald R C, Saeed I T, Khoo D. et al .
Rigorous surveillance protocol increases detection of curable cancers associated with Barrett’s esophagus.
Dig Dis Sci.
2001;
46
1892-1898
33
Csendes A, Burdiles P, Braghetto I. et al .
Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett’s esophagus: the need for long-term subjective and objective follow-up.
Ann Surg.
2002;
235
178-185
34
Corley D A, Levin T R, Habel L A. et al .
Surveillance and survival in Barrett’s adenocarcinomas: a population-based study.
Gastroenterology.
2002;
122
633-640
36
Tabata H, Fuchigami T, Kobayashi H. et al .
Difference in degree of mucosal atrophy between elevated and depressed types of gastric epithelial tumors.
Scand J Gastroenterol.
2001;
36
1134-1140
37
Shimada S, Yagi Y, Shiomori K. et al .
Characterization of early gastric cancer and proposal of the optimal therapeutic strategy.
Surgery.
2001;
129
714-719
38
Roukos D H, Lorenz M, Karakostas K. et al .
Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
Br J Cancer.
2001;
84
1602-1609
40
Fukagawa T, Sasako M, Mann G B. et al .
Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma.
Cancer.
2001;
92
753-760
41
Fujimoto T, Zhang B, Minami S. et al .
Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma.
Oncology.
2002;
62
201-208
42
Lehnert T, Rudek B, Kienle P. et al .
Impact of diagnostic laparoscopy on the management of gastric cancer: prospective study of 120 consecutive patients with primary gastric adenocarcinoma.
Br J Surg.
2002;
89
471-475
43
Rasmussen M, Kronborg O.
Upper gastrointestinal cancer in a population-based screening program with fecal occult blood test for colorectal cancer.
Scand J Gastroenterol.
2002;
37
95-98
44
Saurin J C, Ligneau B, Ponchon T. et al .
The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis.
Gastrointest Endosc.
2002;
55
342-347
45
Park D I, Rhee P L, Kim J E. et al .
Risk factors suggesting malignant transformation of gastric adenoma: univariate and multivariate analysis.
Endoscopy.
2001;
33
501-506
46
Muehldorfer S M, Stolte M, Martus P. et al .
Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study.
Gut.
2002;
50
465-470
47
Whiting J L, Sigurdsson A, Rowlands D C. et al .
The long term results of endoscopic surveillance of premalignant gastric lesions.
Gut.
2002;
50
378-381
48
Sung J J, Lao W C, Lai M S. et al .
Incidence of gastroesophageal malignancy in patients with dyspepsia in Hong Kong: implications for screening strategies.
Gastrointest Endosc.
2001;
54
454-458
49
El-Zimaity H M, Ramchatesingh J, Saeed M A, Graham D Y.
Gastric intestinal metaplasia: subtypes and natural history.
J Clin Pathol.
2001;
54
679-683
50
Hosokawa O, Kaizaki Y, Watanabe K. et al .
Endoscopic surveillance for gastric remnant cancer after early cancer surgery.
Endoscopy.
2002;
34
469-473
51
Lugering N, Menzel J, Kucharzik T. et al .
Impact of miniprobes compared to conventional endosonography in the staging of low-grade gastric MALT lymphoma.
Endoscopy.
2001;
33
832-837
52
Levy M, Copie-Bergman C, Traulle C. et al .
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Am J Gastroenterol.
2002;
97
292-297
53
Raderer M, Osterreicher C, Machold K. et al .
Impaired response of gastric MALT lymphoma to Helicobacter pylori eradication in patients with autoimmune disease.
Ann Oncol.
2001;
12
937-939
54
Delchier J C, Lamarque D, Levy M. et al .
Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
Am J Gastroenterol.
2001;
96
2324-2328
55
Oda I, Kondo H, Yamao T. et al .
Metastatic tumors to the stomach: analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases.
Endoscopy.
2001;
33
507-510
56
Futagami K, Hata J, Haruma K. et al .
Extracorporeal ultrasound is an effective diagnostic alternative to endoscopic ultrasound for gastric submucosal tumours.
Scand J Gastroenterol.
2001;
36
1222-1226